Work

Prostate-specific antigen doubling time is a significant predictor of overall and disease-free survival in patients with prostate adenocarcinoma treated with brachytherapy

Year: 2018

Type: article

Study design: Observational Study

Source: Brachytherapy

DOI: 10.1016/j.brachy.2018.07.008

Authors: Lucas Resende Salgado, Ryan Rhome, William Oh, Nelson Stone, Richard Stock

Institutions: Mount Sinai Hospital, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2884302695

FWCI: 0.188

Cites: 28

Cited by: 1

Related to: 10